11175 Flintkote Ave., Suite E, San Diego, CA 92121
Tel: (303) 730-1950 Fax: (303) 730-1966
Toll free: 1-888-506-6887
E-mail: novus@novusbio.com
web site: http://www.imgenex.com
Quinacrine
Catalog No
: IMG-2012
Contents : 200 mg
Storage : The solid powder is stable in the desiccators at room temperature for 1 year. Water-reconstituted quinacrine solution is stable for up to 1 month at 4oC.
Species Reactivity : N/A
Form : Yellow Solid (Powder)

Inhibitor Mechanism

Endosomal toll-like receptor inhibitor (antagonist); Inhibitor of endosomal acidification on which functional activity of endosomal TLRs (particularly TLR9 and TLR3) is dependent.

Background
Quinacrine is a weak base which can partition into acidic vesicles such as endosomes and lysosomes, resulting in inhibition of endosomal acidification and lysosomal enzyme activity. Because acidic pH of endosomes is a prerequisite of endosomal TLR activation, quinacrine can serve as an antagonist for endosomal TLRs. Quinacrine and its analog chloroquine are also known to act as therapeutic agents for autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus, of which therapeutic activity is due to suppression of TLR9 activity as shown by researchers.
Solubility
Deionized water
Usage

Product Handling Protocol

1. To make 100 mM stock solution, dissolve 200 mg quinacrine in 4.2 ml water by gentle vortex.
2. Filter sterilize through a 0.22 Ám filter.
3. Store at 4oC (Note: Quinacrine solution is light sensitive.).
4. For TLR signaling inhibition study, perform a pilot inhibitory test with the different concentrations of quinacrine ranging from 1 to 10 mM to optimize your experiments.

Note: See our validation tests using the IML-109 (quinacrine sensitive) and IML-102 (quinacrine insensitive) cell lines as shown in Figures 1 and 2.

 

Reference
1. Macfarlane, D. E. et al. (1998). Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160, 1122-1131.
2. Rutz, M. et al. (2004). Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.  Eur. J. Immunol. 34, 2541-2550.
3. Marshak-Rothstein, A. (2006). Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6, 823-835.

Toll free: 1-888-506-6887 Fax: (303) 730-1966 www.imgenex.com novus@novusbio.com 
Research purposes only. Not for diagnostic or in vivo use.